Please use this identifier to cite or link to this item:
http://hdl.handle.net/10397/111848
| Title: | Forecasting myopic maculopathy risk over a decade : development and validation of an interpretable machine learning algorithm | Authors: | Chen, Y Yang, S Liu, R Xiong, R Wang, Y Li, C Zheng, Y He, M Wang, W |
Issue Date: | Jun-2024 | Source: | Investigative ophthalmology and visual science, June 2024, v. 65, no. 6, 40 | Abstract: | PURPOSE. The purpose of this study was to develop and validate prediction model for myopic macular degeneration (MMD) progression in patients with high myopia. METHODS. The Zhongshan High Myopia Cohort for model development included 660 patients aged 7 to 70 years with a bilateral sphere of ≤−6.00 iopters (D). Two hundred twelve participants with an axial length (AL) ≥25.5 mm from the Chinese Ocular Imaging Project were used for external validation. Thirty-four clinical variables, including demographics, lifestyle, myopia history, and swept source optical coherence tomography data, were analyzed. Sequential forward selection was used for predictor selection, and binary classification models were created using five machine learning algorithms to forecast the risk of MMD progression over 10 years. RESULTS. Over a median follow-up of 10.9 years, 133 patients (20.2%) showed MMD progression in the development cohort. Among them, 69 (51.9%) developed newly-onset MMD, 11 (8.3%) developed patchy atrophy from diffuse atrophy, 54 (40.6%) showed an enlargement of lesions, and 9 (6.8%) developed plus signs. Top six predictors for MMD progression included thinner subfoveal choroidal thickness, longer AL, worse best-corrected visual acuity, older age, female gender, and shallower anterior chamber depth. The eXtreme Gradient Boosting algorithm yielded the best discriminative performance (area under the receiver operating characteristic curve [AUROC] = 0.87 ± 0.02) with good calibration in the training cohort. In a less myopic external validation group (median −5.38 D), 48 patients (22.6%) developed MMD progression over 4 years, with the model’s AUROC validated at 0.80 ± 0.008. CONCLUSIONS. Machine learning model effectively predicts MMD progression a decade ahead using clinical and imaging indicators. This tool shows promise for identifying “at-risk” high myopes for timely intervention and vision protection. |
Keywords: | Cohorts Machine learning Myopic macular degeneration (MMD) Visual impairment |
Publisher: | Association for Research in Vision and Ophthalmology | Journal: | Investigative ophthalmology and visual science | ISSN: | 0146-0404 | EISSN: | 1552-5783 | DOI: | 10.1167/iovs.65.6.40 | Rights: | Copyright 2024 The Authors This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License (https://creativecommons.org/licenses/by-nc-nd/4.0/). The following publication Yanping Chen, Shaopeng Yang, Riqian Liu, Ruilin Xiong, Yueye Wang, Cong Li, Yingfeng Zheng, Mingguang He, Wei Wang; Forecasting Myopic Maculopathy Risk Over a Decade: Development and Validation of an Interpretable Machine Learning Algorithm. Invest. Ophthalmol. Vis. Sci. 2024;65(6):40 is available at https://doi.org/10.1167/iovs.65.6.40. |
| Appears in Collections: | Journal/Magazine Article |
Files in This Item:
| File | Description | Size | Format | |
|---|---|---|---|---|
| i1552-5783-65-6-40_1719404850.98668.pdf | 3.52 MB | Adobe PDF | View/Open |
Page views
7
Citations as of Apr 14, 2025
Downloads
2
Citations as of Apr 14, 2025
SCOPUSTM
Citations
7
Citations as of Dec 19, 2025
WEB OF SCIENCETM
Citations
7
Citations as of Dec 18, 2025
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.



